Corporate · Securities 11 min read

Raising capital in Texas: SAFEs, notes, and what investors actually want.

Three instruments dominate early-stage capital raises. Each one defers a different problem to a different moment — and creates a different set of founder trade-offs when that moment arrives. Here is how each one works, what it actually costs, and where the economics are made and lost in the term sheet.

Practice areas this article routes to

If you read nothing else

SAFEs and convertible notes both defer the valuation question — they're fast, cheap to execute, and don't require setting a price for the company today. That deferral isn't free. The three terms that move the most money: the valuation cap on early SAFEs (which sets the ceiling for how cheaply early investors convert in the priced round); the liquidation preference on preferred stock (which determines what investors take before founders see a dollar in a sale); and whether preferred is participating or non-participating (which determines whether investors take their preference and also participate in the upside). None of these are standard. All of them are negotiated. The term sheet decoder below translates the language investors use into what it actually means for your cap table.

Call Chuck Kraus: (682) 529-7177

I've closed a de-SPAC transaction, two dual-listings, and several early-stage capital raises. I've been the GC who was in the room when the term sheet landed and the board needed to understand what they were agreeing to. And I've been the outside counsel who had to explain to a founder, after the fact, why the liquidation preference structure they accepted in a Series A had left them with very little in a $15M exit that felt like a win.

Capital raising sits at the intersection of corporate law, securities law, and negotiating strategy. Most founders who haven't done it before approach it as a commercial negotiation — price, amount, timeline. Experienced investors have done dozens of these. The terms they use casually in a term sheet carry specific legal and economic meanings that aren't obvious from the language. The goal of this article is to close that gap.

Texas has no state securities registration requirements for most private placements that qualify under federal exemptions — primarily Regulation D Rule 506(b) and 506(c), which allow raises from accredited investors without registering the securities. That federal framework is what most early-stage Texas companies use for seed and Series A rounds, and understanding its requirements is the legal foundation for everything that follows.

The three instruments — what each one actually costs

Instrument 01
SAFE — Simple Agreement for Future Equity
Not debt. No maturity date. No interest. Converts at a future priced round.
Pre-Seed · Seed Legal cost: $1K – $5K
How it works

Investor provides capital today. No shares are issued. At a qualifying priced round, the SAFE converts to equity — typically at a discount to the round price, at the valuation cap, or at the lower of the two. Y Combinator's Post-Money SAFE is the current market standard: the cap is applied to post-money valuation, making dilution more predictable for both parties.

Founder trade-offs

No valuation negotiation now — beneficial when the company is early. Fast and cheap to execute. Multiple SAFEs with different caps create a complex conversion structure that surprises founders at the priced round. Pro-rata rights accumulate across SAFE investors and can constrain the lead investor's allocation in the Series A.

Investor view

Simple and founder-friendly instrument. Investors accept it for the discount and the cap — which protect their economics if the company's valuation increases significantly. No creditor rights if the company fails before a priced round: SAFE investors receive proceeds only in a sale or dissolution, after debt is paid.

Watch for

The MFN (Most Favored Nation) clause: some early SAFE investors negotiate a right to receive the terms of any later, more favorable SAFE issued before the priced round. An MFN clause means your first SAFE investor automatically gets the cap from your best seed deal — which can significantly affect the conversion math at the Series A.

Instrument 02
Convertible Note
Debt instrument. Carries interest. Has a maturity date. Converts to equity or must be repaid.
Seed · Bridge Legal cost: $3K – $10K
How it works

Investor makes a loan at a stated interest rate (typically 5–8% annually). The note has a maturity date — typically 18–24 months — at which point, if a priced round has not occurred, the investor can demand repayment in cash or, depending on the note terms, convert to equity at a negotiated price. Conversion in a priced round typically includes principal plus accrued interest.

Founder trade-offs

The maturity date creates a hard deadline for the priced round — or for renegotiating the note. Notes not extended or converted become a balance sheet liability. Many angel investors prefer notes because the debt structure gives them creditor priority over equity holders in a failure scenario. The accrued interest converts, adding to the dilution calculation.

Investor view

Preferred by investors who want creditor protections if the company doesn't make it to a priced round. The interest accrual and maturity date create leverage: a company approaching maturity with no priced round has reduced bargaining power when asking for an extension. Some investors use notes specifically for this leverage effect.

Watch for

Automatic conversion provisions: most notes convert automatically in a "qualified financing" above a threshold amount. Below that threshold, conversion is at the investor's option — giving them leverage to demand better terms or repayment. Negotiate the threshold carefully: a qualified financing set too high means the note converts manually, and at the investor's discretion, in smaller rounds.

Instrument 03
Priced Round — Preferred Stock
Equity issued at a set valuation. No deferral. Investors become shareholders immediately.
Series A · B · Later Legal cost: $50K – $150K
How it works

The company sets a pre-money valuation and issues new preferred shares at a price per share derived from that valuation. Investors receive preferred stock with specific rights and protections. All outstanding SAFEs and convertible notes convert simultaneously as part of the priced round, often creating a complex cap table reconciliation before the round's economics are finalized.

Founder trade-offs

The valuation is set and negotiated — there is no deferral. Board composition changes: institutional investors typically require a board seat, giving them formal governance rights. Protective provisions (investor veto rights over major decisions) are negotiated. Full legal documentation — stock purchase agreement, IRA, ROFR/co-sale, voting agreement — is required, with significant legal cost on both sides.

Investor view

Institutional investors — VC funds — require priced rounds because their fund documents require it. Preferred stock gives investors specific economic protections (liquidation preference, anti-dilution) and governance rights (board representation, protective provisions, information rights) that SAFEs and notes don't provide. The priced round is where the negotiation becomes serious.

Watch for

The pre-money vs. post-money valuation distinction: a $10M pre-money valuation with a $2M raise produces a $12M post-money valuation, and investors own 16.7% of the company. Confusion between pre-money and post-money — which happens more often than it should — produces a cap table that doesn't match either party's expectations. Model the post-money cap table, including SAFE and note conversions, before signing the term sheet.

What investors actually want from a Texas business

The instrument is how the capital is delivered. What investors are actually evaluating is different: a credible path to a return, appropriate for their fund economics and timeline.

Angel investors and family offices in Texas are typically writing $25,000–$250,000 checks into businesses they believe in, often in sectors they understand. They want reasonable terms, clear communication, and a business they can follow without needing a law degree. They are generally more flexible on instrument, more patient on timeline, and more willing to invest in a Texas LLC (rather than a Delaware C-corp) than institutional investors.

Institutional seed funds and VC firms have fund economics that require specific return profiles — they need a small percentage of their investments to return 10x or more to generate acceptable fund returns. This shapes every aspect of how they invest: they invest in large addressable markets because small markets can't produce the exits they need; they prefer Delaware C-corps because the legal infrastructure is established and exit paths are cleaner; and the terms they negotiate — liquidation preference, anti-dilution, pro-rata — are designed to protect their economics in the scenarios where the outcome is good but not a home run.

A term sheet that looks founder-friendly on valuation can be investor-friendly on everything else. The economics live in the details.

The most common mismatch in Texas capital raises: a founder who wants to raise from institutional investors but has structured their business — Texas LLC, no IP formally assigned, complex cap table from informal agreements — in a way that makes institutional investment difficult or expensive to accommodate. Institutional investors are not going to convert a Texas LLC to a Delaware C-corp, clean up unregistered securities, and reconcile informal equity arrangements — they will pass and invest elsewhere. The time to structure for institutional capital is before the first meeting, not during diligence.

The term sheet decoded

The term sheet is where the real negotiation happens. Every provision has a plain-English meaning behind the legal language. These are the six provisions that move the most money.

Term sheet decoder

Six provisions and what they actually mean for founders

Pre-Money Valuation
"The Company shall issue Series A Preferred Stock at a pre-money valuation of $8,000,000."
What it means
This is the agreed value of the company before the investment. The post-money valuation is pre-money + the investment amount. At an $8M pre-money with a $2M raise, investors own 20% post-closing. But this number is calculated before SAFE and convertible note conversions — which dilute everyone, including the new investors. Model the fully diluted cap table before agreeing to the pre-money number.
1x Non-Participating Liquidation Preference
"In the event of a liquidation, dissolution or winding up, Series A holders shall receive 1x their investment before any distribution to Common."
What it means
Investors get their money back first in a sale. Non-participating means they choose either (a) take the 1x preference, or (b) convert to common and share pro-rata. In a large exit, they convert. In a smaller exit, they take the preference. This is the market standard — insist on non-participating. Participating preferred (where investors take the preference and also participate in the upside) can leave founders with very little in a moderate outcome.
Broad-Based Weighted Average Anti-Dilution
"The Series A conversion price shall be subject to broad-based weighted average anti-dilution adjustment."
What it means
If you raise future money at a lower valuation (a down round), investors' shares adjust to give them more equity. Broad-based weighted average is the founder-friendly standard — it moderates the adjustment based on the full diluted share count. Full ratchet anti-dilution is the aggressive version — it resets the conversion price to the lowest price paid in any down round, however small. Never agree to full ratchet.
Protective Provisions
"For so long as any shares of Series A Preferred Stock are outstanding, the Company shall not, without the approval of holders of a majority of Series A..."
What it means
Investors get veto rights over specified major decisions: issuing new stock, amending the charter, paying dividends, incurring significant debt, selling the company. Standard protective provisions are reasonable. Expanded protective provisions — covering operational decisions like compensation, capex, or partnership agreements — significantly constrain day-to-day management. Negotiate the list carefully and understand what requires investor approval before you sign.
Pro-Rata Rights
"Each investor shall have the right to participate in future financing rounds in an amount up to their pro-rata share of such financing."
What it means
Investors can invest in your next round to maintain their percentage ownership. Standard and reasonable. Super pro-rata rights — the right to invest more than their pro-rata share — are occasionally requested by aggressive early investors and can crowd out the new lead investor. Resist super pro-rata. Also consider aggregate pro-rata commitments across all SAFE investors, which can consume a large portion of a future round's available allocation.
Board Composition
"The Board shall consist of five directors: two elected by holders of Common Stock, two elected by holders of Series A Preferred, and one independent director mutually agreed upon."
What it means
Investors get formal governance control commensurate with a 2-of-5 board. The independent director selection process matters: if investors have effective veto over who the independent is, they functionally control three of five votes. Negotiate for founder approval rights on the independent director and for the process by which the independent seat is filled. The board composition at Series A typically persists through Series B and beyond.

Securities law compliance — what you must not skip

Every capital raise is an offering of securities under federal law. Every SAFE, convertible note, and preferred stock issuance is a securities transaction. Failing to comply with the applicable exemptions — primarily Regulation D Rule 506(b) and 506(c) — results in unregistered securities that can be rescinded by investors, creates significant regulatory exposure, and makes future institutional investment significantly more complicated.

The requirements for a 506(b) offering: the company must file a Form D with the SEC within 15 days of the first sale; all investors must be accredited (or up to 35 sophisticated non-accredited investors, though these are uncommon in practice); and the offering cannot be generally advertised or solicited. A 506(c) offering allows general solicitation but requires the company to take reasonable steps to verify that all investors are accredited — more than simply taking their word for it.

Texas also requires a notice filing with the Texas State Securities Board within 15 days of the first sale in Texas for most Regulation D offerings. Failure to make this filing is a technical violation, though not as consequential as the federal failure. Both filings are administrative and inexpensive. Neither requires more than a day to complete. Skipping them because the round was small or informal is the kind of shortcut that becomes expensive in due diligence for the next round.

How I help

I've been on both sides of the term sheet. I know what each provision actually costs.

I've managed capital raises from inside organizations — as the GC who had to explain a liquidation preference structure to a board that didn't fully understand what they'd agreed to, and as the attorney advising the founder before the term sheet was signed. The difference between a good capital structure and an expensive one is almost always made in the negotiation, not the documentation.

I work with Texas founders on entity structuring for investment, SAFE and convertible note documentation, term sheet review and negotiation strategy, and corporate governance design for institutional capital. When transactions reach the complexity of a full priced round, Scale LLP's corporate and securities team handles the documentation. I stay involved as the GC perspective — the person who is thinking about how today's terms affect the exit three years from now.

If you're preparing to raise capital, the most valuable call to make is the one before the first investor meeting, not after the term sheet arrives.

Schedule a Call

Going deeper

Questions I hear from Texas founders thinking about raising capital.

A SAFE (Simple Agreement for Future Equity) is an instrument by which an investor provides capital today in exchange for the right to receive equity in a future priced round. It is not a loan — no interest rate, no maturity date, no obligation to repay in cash. The investor's dollars convert to equity when the company completes a qualifying priced round, typically at a discount to the round price and/or subject to a valuation cap. Y Combinator's Post-Money SAFE is the current market standard. SAFEs have become dominant in early-stage raises because they're fast, cheap, and defer the valuation negotiation. The trade-off: multiple SAFEs with different caps create a complex, sometimes surprising dilution structure when the priced round closes.

Both allow a company to raise capital today and convert to equity later, but they're structurally different. A convertible note is debt — it carries an interest rate (typically 5–8%), has a maturity date (18–24 months), and if it hasn't converted before maturity, the investor can demand repayment of principal plus interest. A SAFE is not debt — no interest, no maturity, no obligation to repay. Investors who want creditor protections prefer notes. Institutional seed funds generally prefer SAFEs. The choice is driven by investor preference and how both instruments will interact with the eventual priced round.

A priced round is an equity financing in which the company sets a valuation, issues new shares at a specific price, and investors receive equity directly. It requires significantly more legal documentation than SAFEs or notes — stock purchase agreement, IRA, ROFR/co-sale, voting agreement — with total legal costs typically $50,000–$150,000. A priced round makes sense when you're raising a larger amount that justifies the cost and complexity, when investors are institutional (VC funds require priced rounds at Series A and beyond), and when the valuation can be defended with financial data. It resolves the valuation question that SAFEs and notes defer — with a more intense negotiation, but a clear cap table afterward.

A liquidation preference lets preferred stockholders receive a specified return before common stockholders in a sale or liquidation. A 1x non-participating preference — the market standard — means investors get back their capital first, but then choose either (a) take the preference, or (b) convert and participate pro-rata. Non-participating is founder-friendly and is the right term to insist on. Participating preferred — where investors take the preference and then also participate in remaining proceeds — can dramatically reduce founder proceeds in moderate outcomes. Model the economics under your liquidation preference structure at different exit valuations before signing.

Anti-dilution provisions protect preferred stockholders if the company raises capital in a future round at a lower valuation than the round in which they invested. There are two types. Broad-based weighted average anti-dilution is the market standard and is relatively founder-friendly — it adjusts the conversion price based on the weighted average of all shares issued in the down round. Full ratchet is the aggressive version — it resets the conversion price to the lowest price paid in the down round, regardless of how small that round was. Full ratchet can be catastrophic for founders in a down round: even a small investment at a lower price gives early investors so many additional shares on conversion that founders may be left with negligible ownership. Never agree to full ratchet.

A pro-rata right allows an existing investor to participate in future rounds in proportion to their current ownership, to maintain their percentage rather than being diluted. Standard pro-rata rights are reasonable — investors value them, and they signal confidence in the company. Super pro-rata rights — the right to invest more than their pro-rata share — are occasionally demanded and should generally be resisted, as they can crowd out the new lead investor. Practically, aggregate pro-rata commitments across multiple SAFE investors can become unwieldy and need to be managed carefully before a priced round closes.

A term sheet sets out the proposed terms of an investment before full legal documentation. It covers the key economic and governance terms: pre-money valuation, investment amount, type of security, liquidation preference, anti-dilution, board composition, protective provisions, and information rights. Most economic and structural terms are non-binding until definitive agreements are signed. However, exclusivity (preventing the company from soliciting other financing for 30–60 days) and confidentiality are typically binding. Treat the term sheet as a serious commitment even though it's not legally binding on deal terms — backing out after the investor has incurred significant diligence costs damages your reputation in a community that is smaller than it looks.

Protective provisions require preferred stockholder consent before the company can take specified significant actions — issuing new stock, amending the charter, selling the company, incurring significant debt. Standard protective provisions are reasonable investor protections. Expanded protective provisions covering operational decisions like compensation, capex, or acquisitions significantly constrain day-to-day management and create ongoing friction. The scope is negotiable — evaluate each proposed provision carefully. Understand exactly which actions require investor approval before signing, and model how those approvals will work operationally as the business grows.

The most valuable call is the one
before the term sheet arrives.

Fifteen minutes on structure and strategy before the first investor meeting is worth more than any amount of negotiation after the term sheet is on the table.

This article provides general information about capital raise structures and securities law compliance and is not legal advice for your specific situation. Securities offerings are governed by both federal and state law, and the requirements depend on the specific structure, the investors, and the amount raised. Consult a securities attorney before completing any capital raise. Nothing in this article constitutes an offer or solicitation of securities. Chuck Kraus is licensed in Texas, Minnesota, Washington State, and Canada.